We glide into the long weekend with a report from an Ingress event held in Detroit on Aug. 23, an update on three expanding local tech startups, and brief, gloating commentary on the new story about Detroit in Time magazine. Have... Read more »
To get ready for the annual post-Labor Day market revival, three Boston-area biotechs have put their IPO plans on the front burner. Syndax Pharmaceuticals has come back to the table after postponing its plans earlier this year, while Rhythm Pharmaceuticals and... Read more »
[Corrected 8/30/14, 1:51 p.m. See below.] It’s a “dangerous time” for the VC world because the majority of the industry’s money is concentrated in a relatively small number of firms, primarily in Silicon Valley. And that makes it tougher... Read more »
On this end-of-summer week, we’re following fresh funding for Techstars Seattle company Bizible, seven startups selected for accelerator Fledge, a name change for the WCTA, a standout series on Amazon in Europe, and more:
—Bizible, a Seattle startup helping... Read more »
Here is a quick roundup of some news from Colorado startups and tech companies, featuring TeamSnap and Corgenix, which is making a test for the Ebola virus.
TeamSnap Snaps Up Competitor: TeamSnap, a Boulder, CO-based startup, continues to grow. This week,... Read more »
An experimental Ebola drug from BioCryst Pharmaceuticals (NASDAQ: BCRX) now has funding for tests in monkeys, a step away from testing the treatment in humans.
BioCryst says it expects tests of its experimental Ebola treatment will start “within weeks.” The... Read more »
The “hot zone” in West Africa that has become the worst Ebola outbreak in history is now a full-blown global health crisis—and it is expected to continue into 2015.
That is the consensus of three Ebola experts who, speaking at a... Read more »
[Corrected 8/29/14, 8:39 a.m. See below.] Madison Vaccines, a Madison, WI-based startup developing immunotherapies for prostate cancer, will get a chance to see how well its lead vaccine can shrink tumors when teamed up with another drug.
The Phase... Read more »
Lots of news this week up and down the coast and up and down the biotech food chain. We’ve got a new twist (or fold, if you prefer) on academic Ebola research at the University of Washington, and new workspace for... Read more »